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Abstract
Background: Health care providers need solid evidence based data on cost differences between alternative
surgical procedures for common surgical disorders. We aimed to compare small-incision open cholecystectomy
(SIOC) and laparoscopic cholecystectomy (LC) concerning costs and health-related quality of life using data from an
expertise-based randomised controlled trial.
Methods: Patients scheduled for cholecystectomy were assigned to undergo LC or SIOC performed by surgeons in
two different expert groups. Total costs were calculated in USD. Reusable instruments were assumed for the cost
analysis. Quality of life was measured using the EuroQol 5-D 3-L (EQ 5-D-3L), at five postoperative time points and
calculated to Area Under Curve (AUC) for 1 year postoperatively. Two hospitals participated in the trial, which
included both emergency and elective surgery.
Results: Of 477 patients that underwent a cholecystectomy during the study period, 355 (74.9%) were randomised
and 323 analysed, 172 LC and 151 SIOC patients. Both direct and total costs were less for SIOC than for LC patients.
The total costs were 5429 (4293–6932) USD for LC and 4636 (3905–5746) USD for SIOC, P = 0.001. The quality of life
index did not differ between the LC and SIOC groups at any time. Median values (25th and 75th percentiles (p25-p75))
for AUC at 1 year were as follows: 349 (337–351) for LC and 349 (338–350) for SIOC.
Conclusions: In this expertise-based randomised controlled trial LC was a more costly procedure and quality of life did
not differ after SIOC and LC. (ClinicalTrials.gov Identifier: NCT00370344, August 30, 2006).
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Background
Over the past three decades, there has been substantial
development in cholecystectomy techniques, as well as
in the pre- and post-operative management of patients.
The open surgical procedure with a large incision (OC)
[1] has been succeeded by small incision open cholecyst-
ectomy (SIOC) [2, 3], laparoscopic cholecystectomy [4],
single port laparoscopic cholecystectomy technique [5, 6],
robotic cholecystectomy [7], and single port robotic chole-
cystectomy [8]. It is essential to scrutinise such changes in
surgical technology in terms of cost and quality of life, to
ensure fair distribution of resources. A meta-analysis of
earlier randomised controlled trials showed no statis-
tically significant differences, in terms of postoperative
clinical outcomes, between SIOC and LC, but a sig-
nificantly shorter operating time for SIOC [9]. Similar
findings were reported in an expertise-based rando-
mised controlled trial [10]. The aim of the present
study is to compare LC and SIOC concerning costs
and quality of life assessed by the EuroQol-5D-3L
[11] using data from this expertise-based randomised
controlled trial [12].
Methods
Details concerning surgical teams and surgical tech-
niques including intra-operative cholangiogram have
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been described earlier [10]. Primary outcomes were costs
and health related quality of life, reported in the current
paper, and pain. Secondary outcomes were complica-
tions within 30 days, operative time, length of hospital
stay, conversion rate, frequency of ambulatory surgery
and readmissions within 30 days, which together with
pain have been reported earlier [10]. In short, SIOC was
performed via a transverse incision over the right rectus
muscle and laparoscopic cholecystectomy with a four-
trocar technique. If the SIOC incision exceeded 8 cm,
the operation was classified as an open cholecystectomy
as this was the cut-off in the Swedish registry for gall-
stone surgery (GallRiks) [13]. Two hospitals participated
in the trial, Umeå University Hospital and Lycksele
County Hospital. The study was designed as a rando-
mised pragmatic expertise-based trial [12, 14], where
participating surgeons were asked to join one of two
teams, performing either SIOC or LC, according to their
personal preferences. Team members performed their
specific method (SIOC or LC) as a first-choice oper-
ation, but converted to OC when necessary, and even
began the operation using OC when neither LC nor
SIOC were considered possible.
Patients
Eligible patients were asked to enrol in the trial at the
time when cholecystectomy was decided. Written in-
formed consent was obtained before randomisation. The
trial was not blinded.
Inclusion and exclusion criteria
Patients aged 18 years or older with biliary disease where
cholecystectomy was considered the best treatment ac-
cording to published recommendations [15, 16] were
asked to participate in the trial. Both elective and emer-
gency patients were enrolled. Patients with acute chole-
cystitis, choledocholithiasis, jaundice, pancreatitis,
obesity and co-morbidity were included if cholecystec-
tomy was considered the best treatment. The exclusion
criteria were: inability to understand given information,
surgeons from either the LC team or the SIOC team un-
available for emergency cholecystectomy, cholecystec-
tomy performed for malignant disease or suspicion of
malignancy, and cholecystectomy performed as part of
another operation.
Randomisation
Randomisation was made using an internet-based system
with computer-generated random numbers. Patients
were automatically stratified at three levels: hospital, age
(< or > = 70 years), and degree of priority (elective, emer-
gent, or surgery for life-threatening disease). The pa-
tients were randomised when the decision for surgery
was made.
Economic analysis
The economic analysis was conducted from a societal
perspective, calculating both direct public healthcare
costs and indirect costs generated by the loss of product-
ivity (sick leave). Cost generating posts in health care
were calculated from the time the patient was admitted
for surgery. Preoperative investigations (preoperative
radiology, preoperative visits to outpatient clinic, etc.)
were not included. Costs for pre-, intra-, and postopera-
tive endoscopic retrograde cholangiogram (ERC),
sphincterotomy and endoscopic stone extraction were
regarded as a part of the operative procedure and were
thus included. Detailed calculations of cost items were
performed in one hospital (Umeå University Hospital).
All costs are given as USD. Where reliable item costs
could be found, they were retrieved from the Hospital
Department of Economics (costs for perioperative and
secondary cholangiogram, in hospital stay, postoperative
recovery unit). Other costs were calculated manually,
(disposables, reusable instruments, including laparo-
scopic equipment). Costs for LC were calculated with
the presumption of reusable trocars. Personnel costs per
minute were calculated using mean wages for each cat-
egory of personnel obtained from the Department of
Economics, Umeå University Hospital. Costs for social
benefits and employer fees, at a rate of 43.71% (mean for
hospital staff ), were added to the mean wages. Oper-
ational costs were calculated with one resident and one
senior surgeon participating from incision to last stich
for each operation. A standard cost for counselling and
administration (hospital record, sick leave certificate and
prescription of drugs) were added. The cost for surgical
theatre staff was calculated from the moment patients
arrived at the theatre until they left for the recovery unit,
individually for each patient. All patients were estimated
to spend 4 h in the postoperative recovery unit. Patients
undergoing ambulatory surgery were estimated to spend
8 h in the surgical ward. An average cost for ERC,
sphincterotomy and endoscopic stone extraction of 1216
USD, was estimated by the Hospital Department of Eco-
nomics. Indirect costs due to loss of production were
calculated based on mean wages obtained from Statistics
Sweden (SCB) for men and women, respectively, includ-
ing social benefits and employer fees at a rate of 41.15%
(mean for all employed). Indirect costs were calculated
only for patients that reported taking a sick leave from
work due to the operation. Cost-generating posts are
listed in Table 1.
Health-related quality of life
Health-related quality of life was assessed using the EQ
5-D-3L (EuroQol Group, Rotterdam, The Netherlands
[11]) which consists of five questions concerning patient
mobility, self-care, usual activities, pain/discomfort and
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anxiety/depression. In this study, a value set derived
from the Swedish population was used [17]. The EQ-
5D-3L index values were further calculated to AUC and
quality adjusted life years (QALYs), please see Sample
size, analysis and statistics.
Data collection
The operating surgeon registered the operative data (ex-
cept for operative time) in the Swedish registry for gall-
stone surgery, GallRiks [13]. An independent assessor, as
defined by GallRiks, registered operative time, length of
hospital stay and complications within 30 days. Compli-
cations were graded according to Dindo-Clavien [18].
Health-related QoL was recorded by the patient before
surgery and on postoperative days 3, 7, 11, and 30, as
well as 1 year after surgery. The patient reported length
of sick leave at 30 days. Data from GallRiks were con-
trolled against patient hospital records for all patients.
Where registration errors were detected, they were
corrected.
Sample size, analysis and statistics
The power calculation to determine the sample size for
the trial was based on earlier publications on cholecyst-
ectomies where the main differentiating factor between
the two interventions was duration of the operation. It
was assumed that SIOC would take 16 min less com-
pared to LC, based on three previous studies [19–21].
The calculation was made for 90% power, 5% signifi-
cance level and an anticipated data loss of 25%. With
these assumptions, it was calculated that the study
should consist of at least 350 patients. The sample size
was estimated to be sufficient for detecting significant
differences of routine costs, but not for comparing rela-
tively rare complications between groups. All analyses
were made with the intention-to-treat principle. Quanti-
tative results were presented as median values, 25 and
75th percentiles whenever the distribution of the data
was skewed. A non-parametric Mann-Whitney U test
was used for statistical tests of significance. AUC (Area
Under Curve) values up to 1 year were calculated using
the EQ-5D-3L scores at five different postoperative time
points and the assumption that the change between time
points was linear. Missing EQ-5D-3L values were impu-
tated if the case had at least two registered genuine EQ-
5D-3L values at different time points, otherwise the case
was excluded from AUC calculation. We used the
principle to add (or subtract) the mean change between
specific time points for the group (LC or SIOC) to the
last genuine value to generate the value for the next time
point if it was missing. In all, 128 imputations for miss-
ing values were added to the 1372 genuine values.
Thirty-three cases were excluded because of more than
three missing EQ-5D-3L scores. The EQ-5D-3L scores
and AUC values were calculated from raw data using
Microsoft® Excel for Mac version 14.2.3 (Microsoft
Corporation, Redmond, Washington, USA), and Stata®
software release 13.1 (StataCorp LP, College Station,
Texas, USA) was used for statistical calculations.
Results
A flow diagram describing the progress from enrolment
to analysis according to the CONSORT statement [22] is
presented in Fig. 1. Of 477 assessed patients, 355
(74.9%) were randomised. Twenty-two patients (LC 6
and SIOC 16) were excluded from analysis of which 18
declined surgery, two were operated on at a non-
participating hospital and 2 were operated on for other
non-related disease. Finally 333 were analysed, 177 LC
and 156 SIOC patients. Of these 333 patients, postoper-
ative QoL data was available and analysed for 290, 156
LC and 134 SIOC patients. Study protocol violations
were noted for 33 patients. In accordance with the
CONSORT Statement [22] cases with protocol violations
were not excluded, but were analysed according to the
original randomisation.
Baseline data
Age, sex, preoperative EQ-5D-3L score, proportion of
smokers, proportion employed and education level were
Table 1 Cost-generating items and unit costs
Cost item Unit cost, USD Cost category
Preoperative ERC 1216.00 Other HCC
Perioperative cholangiogram 295.79 Op cost
Material costs/operation Op cost
LC 481.38
LC converted to OC 559.51
SIOC 419.67
SIOC converted to OC 419.67
Surgeons costs/min 4.27 Op cost
Anaesthesia cost/min 2.64 Op cost
Other staff costs/min 3.66 Op cost
Facilities costs/min 1.60 Op cost
Fixed costs operating staff/operation 757.11 Op cost
Recovery unit costs/operation 267.37 Other HCC
Secondary cholangiogram costs 197.14 Other HCC
Postoperative ERC cost 1216.00 Other HCC
Hospitalisation cost/day 817.30 Other HCC
Readmission cost/day 817.30 Other HCC
Sick leave costs men/day 210.67 Indirect costs
Sick leave costs women/day 181.18 Indirect costs
Other HCC other health care costs, Op cost cost generated by operation, LC
laparoscopic cholecystectomy, OC open cholecystectomy, SIOC small-incision
open cholecystectomy
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similar between the groups (Table 2). The SIOC-group
had a longer time between decision for surgery and op-
eration [10], 156 versus 103 days, respectively (P = 0.03),
slightly more emergency admissions, and more cases
with acute cholecystitis than the LC group, 25.6 and
14.7%, respectively (p = 0.012).
Outcomes
The median value for direct cost was (p25-p75) 4210
USD (3851–5073) for the LC group and 3963 USD
(3512–4848) for the SIOC group, P = 0.002. Operation
costs and total costs, including indirect costs, were sig-
nificantly higher for the LC group, p = <0.001 and p =
0.003 respectively (Table 3).
EQ-5D-3L-AUC within 1 year was, median, (p25-
p75) 349 (337–351) for the LC group and 349 (338–
350) for the SIOC group, P = 0.8096. QALYs had a
median of 0.9639 (0.9313–0.9683) and 0.9636
(0.9343–0.9679) in the LC group and SIOC group,
respectively. EQ-5D-3L-AUC at 30 days was, median
(p25-p75) 25.17 (23.70–25.85) for the LC group and
25.10 (23.67–25.76) for the SIOC group. Index
values for EQ-5D-3L at all time points are shown in
Fig. 2. Subgroup analyses for costs and QoL of
patients that had emergency cholecystectomy,
elective cholecystectomy, complications and no
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Fig. 1 CONSORT diagram for the trial. Analysis according to the ‘intention to treat’ principle. (Modified reprint from Br J Surg 2013;100(7): 886–894,
with written permission from original publisher John Wiley and Sons)
Table 2 Patient characteristics for 333 patients
LC SIOC
n = 177 n = 156
Male/Female % (n) 38/62 (68/109) 39/61 (61/95)
Age in years, median (range) 52 (18–84) 51.5 (20–84)
Preoperative EQ-5D-3L score, Median (p25, p75) 0.9349 (0.8337–0.9349) 0.9349 (0.8337–0.9694)
Patients with QoL data 153/177 131/156
Employed % (n) 58 (89/154) 55 (73/133)
Smoker % (n) 16 (23/148) 10 (13/132)
Higher education % (n) 29 (44/150) 32 (43/135)
LC laparoscopic cholecystectomy, SIOC small-incision open cholecystectomy, EQ-5D-3L EuroQol-5D-3L instrument for assessment of quality of life, QoL quality of life
Proportion of subgroup is presented when there was missing data
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Discussion
In this expertise - based RCT, LC carried significantly
higher costs than SIOC, direct as well as indirect costs
but there were no significant differences in health-
related QoL between the LC and SIOC group when
measured with EQ-5D-3L.
In accordance with previous studies [9], the present
trial has not demonstrated significant differences in
complication rate between LC and SIOC [10]. It was de-
signed as a pragmatic randomised expertise-based trial
[14] with the intention to minimise exclusions and dif-
ferential bias [12, 14]. The expertise-based setting made
it possible to include patients otherwise unfit to be in-
cluded in a regular trial such as patients with prior
upper gastro-intestinal surgery, patients with mild biliary
pancreatitis, and patients with acute cholecystitis. There-
fore, we had a high percentage of patients assessed for
cholecystectomy included in the trial (75%). Operating
times in the present study were longer for LC than for
SIOC in accordance with previous studies [9]. Our oper-
ating times were long reflecting the high inclusion ratio
with the ambition to include also acute operations. A
setting with disposable trocars and clip applier would
have added an estimated 304 USD to the perioperative
costs for the LC group.
There are some potential limitations to this study.
First, after completion of the study we found that
time from randomisation to cholecystectomy was
longer for SIOC than for LC patients [10]. We had
fewer SIOC surgeons than LC surgeons, 6 vs 11.
This increased the time on waiting list for SIOC pa-
tients, some of which had to be operated emergently.
Consequently, more patients with acute cholecystitis
appeared in the SIOC group, which explains the
slightly higher pain score and VAS-QoL score pre-
operatively for SIOC patients [10]. However, in the
present report only the validated EQ-5D-3L instru-
ment was utilised for quality of life estimation. Sec-
ond, measuring indirect costs (e.g. sick leave) can be
considered controversial, as it may reflect local tradi-
tions as well as political and cultural differences. In
Sweden, a doctor’s certificate is required after the
seventh’ day of sick leave. The study protocol stated
that sick leave certificates should not routinely be
written after uncomplicated surgery. In this study,
LC patients had a higher cost for loss of production
(indirect costs) without QoL difference. This might
reflect that surgeons in the SIOC group, after the
SIOC training phase were more compliant to the
study protocol than the LC group surgeons. This im-
balance in sick leave was also found in an earlier
study [23].
Several reasons necessitate a discussion of cost-
effectiveness in treatment of gallstone disease. The
increasing population age in industrialized countries
escalates health care costs [24]. Sphincterotomy has
separated treatment of bile duct stones and gallblad-
der stones [25, 26], although SIOC, with choledochot-
omy, and primary closure of the common bile duct
during cholecystectomy is safe, effective and inexpen-
sive when performed by trained surgeons [27]. The
decline in training in open surgery for residents [28]
is of concern for the treatment of gallstone disease
[29, 30]. After appropriate training, SIOC is an alter-
native to LC wherever the health-care budget is lim-
ited, not only in the third world [31].
Conclusions
From this trial we conclude that LC is more costly, but
SIOC and LC are comparable in terms of QoL.
Table 3 Cholecystectomy costs for all patients
LC (n = 177) SIOC (n = 156) P b
Total costs with loss of production (sick leave) included a
Median 5442.06 4783.90 0.003
p25-p75 4323–7000 3919–5906
Total costs, loss of production omitted a
Median 4210 3963 0.002
p25-p75 3851–5073 3512–4848
Operation costsa
Median 3183 2882 <0.001
p25-p75 2959–3479 2638–3320
aAll costs are given in USD
bComparision with Mann-Whitney test
















Preop 3rd day 7th day 11th day 30th day 1 year
LC, p5/p95 SIOC, p5/p95
LC, p25/p75 SIOC, p25/p75
LC, median (p50) SIOC, median (p50)
Fig. 2 Health-related quality of life (QoL) scores before operation
and at five postoperative time points, measured with the EQ-5D-3L
scale, with scores ranging from 0 to 1, where 1 is the best possible
health-related quality of life. Values are presented as the median and
as percentiles 25 to 75th (box) and 5 to 95th percentile
range (whisker)
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Additional file 1: Table S1. Subgroup analyses. Additional file holds a
supplementary table (Table S1) with subgroup cost and QoL analysis of
patients that had a) emergency cholecystectomy, b) elective
cholecystectomy, c) complications and d) no complications. (DOCX 18 kb)
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